About Resbiotic
Resbiotic is a company based in Birmingham (United States) founded in 2021 by C Vivek Lal. Resbiotic has raised $19.64 million across 6 funding rounds from investors including HHS, Timberline Holdings and BioStack Ventures. Resbiotic offers products and services including resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic. Resbiotic operates in a competitive market with competitors including Novozymes, Pendulum, Seed, Seres Therapeutics and MaaT Pharma, among others.
- Headquarter Birmingham, United States
- Founders C Vivek Lal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$19.64 M (USD)
in 6 rounds
-
Latest Funding Round
$8 M (USD), Series A
Sep 12, 2025
-
Investors
HHS
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resbiotic
Resbiotic offers a comprehensive portfolio of products and services, including resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic.
Supports lung health with scientifically formulated probiotics.
Combines probiotics for comprehensive gut health support.
Enhances energy and gut function through prebiotic fibers.
Aids metabolic health with postbiotic compounds.
People of Resbiotic
Unlock access to complete
Unlock access to complete
Funding Insights of Resbiotic
Resbiotic has successfully raised a total of $19.64M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $8 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Resbiotic
Resbiotic has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Timberline Holdings and BioStack Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Timberline Holdings is focused on family investment and growth.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Resbiotic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resbiotic
Investment portfolio details for Resbiotic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Resbiotic
Detailed financials for Resbiotic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resbiotic Comparisons
Peer comparison for Resbiotic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resbiotic
Resbiotic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Pendulum, Seed, Seres Therapeutics and MaaT Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| Locked | Locked | Locked |
Pendulum is focused on developing advanced probiotic solutions.
|
|
| Locked | Locked | Locked |
Synbiotics are developed for simulating the gut microbiome.
|
|
| Locked | Locked | Locked |
Microbiome therapeutics are developed to address diverse diseases.
|
|
| Locked | Locked | Locked |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
|
| Locked | Locked | Locked |
Microbiome-based immuno-oncology drugs are developed using proprietary technology.
|
Detailed competitors of Resbiotic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resbiotic
Complete news archive for Resbiotic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resbiotic
Resbiotic was founded in 2021.
Resbiotic is headquartered in Birmingham, United States. It is registered at Birmingham, Alabama, United States.
C Vivek Lal is the current CEO of Resbiotic. They have also founded this company.
Resbiotic is a funded company, having raised a total of $19.64M across 6 funding rounds to date.
Resbiotic was founded in 2021 in Birmingham, United States, as a provider in the health supplements sector. Physician-formulated products, including probiotics, prebiotics, and postbiotics, are offered to restore gut health and aid lung, gut, and metabolic functions. Operations focus on delivering these supplements through an online domain, resbiotic.com, targeting wellness needs in the United States.
Resbiotic's top competitors include Novozymes, The Good Bug and Pendulum.
Resbiotic offers resB® Lung Support Probiotic, Power Gut Bundle, resG prebeet® ENERGY Prebiotic, and resM™ GLP-1 Postbiotic.
Resbiotic has 3 investors. Key investors include HHS, Timberline Holdings, and BioStack Ventures.